Investing.com - Stocks in focus in premarket trading on Monday: Celgene (NASDAQ:CELG) stock rose 3.7% in premarket trade by 8:30... Investing.com - U.S. futures pointed to a surge on Wall Street ...
Buying has spiked in a number of companies developing targeted cancer therapies after Eli Lilly (NYSE:LLY)'s $8B takeout of Loxo ...
Discover 25 top investment-grade stocks to buy! See strategies to capitalize on market volatility and build a portfolio to ...
Celgene's European leader Tuomo Pätsi talks to pharmaphorum about the firm's remarkable growth, which is set to continue thanks to myeloma blockbuster Revlimid and new psoriasis and psoriatic ...
over 6000 assets (including all Forex pairs, Cryptocurrencies, Commodities, Indices and US stocks) unique interbank rates extensive historic data the option to save your configuration Here below ...
BMS plans to separate its R&D into early- and late-stage divisions, with Celgene’s Rupert Vessey earmarked to lead the former and new recruit Samit Hirawat – formerly head of oncology R&D of ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stock. Also, suppose you choose stocks in promising industrial sectors or ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
allowing you to participate more actively in the construction of your portfolio. Consider Benzinga's favorite brokerages and penny stock apps.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results